Cure.

🎥 Watch Cure CEO Seema Kumar share her bold vision for the future of healthcare innovation. In this powerful talk, hosted by STAT Brand Studio, Seema introduces Cure not just as a space, but a collaborative ecosystem uniting scientists, entrepreneurs, and innovators to transform healthcare. " Breakthroughs don’t happen overnight. That’s why Cure brings together entrepreneurs, academics, and industry leaders under one roof—to convene, connect, and co-create. It’s where ideas evolve, partnerships form, and discovery is accelerated through shared purpose, says Kumar." ▶️ Don’t miss this inspiring talk as Seema talks about the future of healthcare and how, at Cure, we are supporting the next wave of innovators. #wewillcure #healthcareecosysstem #entrepreneurs #innovators #scientists

Headed to BIO this year? If so, head to WIB@BIO 2025 to listen to Cure CEO Seema Kumar, Cancer Vaccine Coalition Founder Kristen Dahlgren, and Claire Love from PwC for a robust conversation on Women's health innovation.

Digital health tools are empowering women globally, increasing their decision-making and autonomy while improving access to care. 📚A new study in The Lancet Group highlights how mobile apps, AI platforms, and messaging services help women worldwide to manage pregnancies, mental health, and more, especially in underserved areas. Yet, barriers like digital divides and funding gaps persist. 🔗Read more: https://lnkd.in/ed3Pv-aF #womenshealth #femtech #digithealth

💥Happening Today at Cure: Resident company Wandercraft opens its first U.S. clinic, Walk, in New York. This groundbreaking facility offers personalized rehabilitation using Atalante X, the world’s first self-balancing, hands-free exoskeleton, to patients with spinal cord injuries, strokes, and other neurological conditions. Developed in collaboration with licensed physical therapists, the clinic blends robotics, immersive virtual therapy, and advanced gait analysis to support mobility recovery — no upper body strength required. “Walk in New York” also marks a major step forward the company’s plan to launch its Personal Exoskeleton for everyday home use — making independent mobility more accessible than ever. 🎥 Watch one of their patients, Zachary, stand up and proudly take a few steps and click to learn more. https://lnkd.in/dVBY7aq6 #exoskeleton #mobilitytech #wewillcure #NYCHealth #robotics

🚨Biden’s Prostate Cancer Diagnosis: A Wake-Up Call for Innovation Former President Biden’s recent diagnosis of metastatic #prostatecancer spotlights the pressing need for improvements in both the detection and treatment of this disease. Startups such as Avenda Health, Francis Medical, Lucida Medical Ltd Cleveland Diagnostics, Gregor Diagnostics, and Exact Imaging are at the forefront, utilizing AI-driven diagnostics and precision therapies. Cure reporter Ryan Flinn explores in detail how these innovators are transforming the future of men's health: https://lnkd.in/epUZVQp9 #Biden #wewillcure #PresidentBiden #cancer #precisionmedicine

Cure Asked: How did your individual learning journey lead to collaboration—and ultimately spark the creation of GenKardia. 2025 XSeed Award winner Richard Nkulikiyinka MSc, MBBChir, MRCP, co-founder of GenKardia, shares how personal insight evolved into team-driven innovation—paving the way for breakthroughs in treating #heartdisease.                                                         Watch, then click to learn more about Nkulikiyinka’s lessons for new #entrepreneurs. https://lnkd.in/eW3SC3TB #wewillcure #XSeed

Tomorrow at Cure! Join us tomorrow to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. Register to Exhibit: https://lnkd.in/gRW2tmH Register to Attend:  https://lnkd.in/gMp7e7Gb

From the White House to the Boardroom In an exclusive interview with Cure, Dan Mendelson—leading J.P. Morgan Chase's bold $250M commitment to transform employer-sponsored healthcare—shares the vision behind Morgan Health. The investment is a strategy aimed at empowering market-tested solutions with data analytics, strong management expertise, and a ‘learning lab’ approach to pilot and refine healthcare in real-time. 🔗 Read more on Morgan Health's program and what's ahead:  https://lnkd.in/erMD27_5 #employerhealthcare #investment #jpmorgan #dataanalytics Wendy Diller

🎤 Live from Cure: Proud to host SiS New York 2025! Today, Cure is thrilled to welcome SiS: Women's Health for their first-ever U.S. conference, bringing together leading voices dedicated to advancing innovation in women’s health. The day opened with a powerful conversation on a long-overlooked opportunity: the gender data gap. Cure CEO Seema Kumar kicked off the opening day panel, Solving the Gender Data Gap: Innovation's Next Frontier, joined by: ♦️ Sarah Cross, PhD, Premier Research ♦️Priyanka Jain, Evvy ♦️Danika Kelly, My Normative ♦️Amanda Ducach, MBA, Ema - The AI for Women Kumar said, "What doesn't get measured doesn’t get funded, and what doesn't get funded doesn’t get solved. For more on solutions for the health of women: https://lnkd.in/eMDtPScW #wewillcure #womenshealth #SiSNewYork2025 #Healthdata #genderequity #innovation

💡 Innovation doesn’t stop—especially in hard times! At a recent panel hosted at Cure and moderated by Cure CEO Seema Kumar, panelists explored how healthcare startups must embrace creative funding, strategic focus, and resilient leadership during tough market times. Kumar emphasized, “Despite the challenging environment that we’re in, innovation will actually continue on, and we will find ways to take this mission to market.” Biotech board member and advisor Rekha Hemrajani added: “I think this is one of the more challenging times that I have experienced. Management teams have to become creative, and I think this industry is one of the most creative, most innovative industries that we have.” 🔗 Read more panelists’ advice to early-stage biotech founders on building amid uncertainty. https://lnkd.in/ef-NqvQ3 Erika Smith, EpiTET Therapeutics, Rekha Hemrajani, CDR Michael Banyas, USPHS, MPA #wewillcure #startupadvice #investor #healthcare #innovation